Ibuprofen Topicals Draw Unapproved New Drug Warnings
This article was originally published in The Tan Sheet
Executive Summary
FDA's initiative to remove unapproved new drugs from the market extends to topical ibuprofen products as the agency warns eight firms about lotions containing the common nonprescription ingredient
You may also be interested in...
GSK Pursues Futura Medical's OTC Topical NSAID Under Development
GlaxoSmithKline's relationship with Futura Medical is on again as the pharmaceutical giant agrees to fund development of Futura's novel topical pain reliever TPR100
GSK Pursues Futura Medical's OTC Topical NSAID Under Development
GlaxoSmithKline's relationship with Futura Medical is on again as the pharmaceutical giant agrees to fund development of Futura's novel topical pain reliever TPR100
GSK Pursues Futura Medical's OTC Topical NSAID Under Development
GlaxoSmithKline's relationship with Futura Medical is on again as the pharmaceutical giant agrees to fund development of Futura's novel topical pain reliever TPR100